Klotho Neurosciences (KLTO) Competitors $0.16 -0.01 (-2.94%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock KLTO vs. ALLR, NAII, CMMB, EDSA, SLGL, EQ, LPCN, CING, UBX, and BFRGShould you be buying Klotho Neurosciences stock or one of its competitors? The main competitors of Klotho Neurosciences include Allarity Therapeutics (ALLR), Natural Alternatives International (NAII), Chemomab Therapeutics (CMMB), Edesa Biotech (EDSA), Sol-Gel Technologies (SLGL), Equillium (EQ), Lipocine (LPCN), Cingulate (CING), Unity Biotechnology (UBX), and Bullfrog AI (BFRG). These companies are all part of the "pharmaceutical products" industry. Klotho Neurosciences vs. Allarity Therapeutics Natural Alternatives International Chemomab Therapeutics Edesa Biotech Sol-Gel Technologies Equillium Lipocine Cingulate Unity Biotechnology Bullfrog AI Allarity Therapeutics (NASDAQ:ALLR) and Klotho Neurosciences (NASDAQ:KLTO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking. Does the media prefer ALLR or KLTO? In the previous week, Allarity Therapeutics had 2 more articles in the media than Klotho Neurosciences. MarketBeat recorded 3 mentions for Allarity Therapeutics and 1 mentions for Klotho Neurosciences. Klotho Neurosciences' average media sentiment score of 0.94 beat Allarity Therapeutics' score of 0.79 indicating that Klotho Neurosciences is being referred to more favorably in the news media. Company Overall Sentiment Allarity Therapeutics Positive Klotho Neurosciences Positive Do insiders and institutionals hold more shares of ALLR or KLTO? 11.5% of Allarity Therapeutics shares are held by institutional investors. Comparatively, 20.1% of Klotho Neurosciences shares are held by institutional investors. 0.1% of Allarity Therapeutics shares are held by company insiders. Comparatively, 2.0% of Klotho Neurosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in ALLR or KLTO? Allarity Therapeutics received 1 more outperform votes than Klotho Neurosciences when rated by MarketBeat users. CompanyUnderperformOutperformAllarity TherapeuticsOutperform Votes150.00% Underperform Votes150.00% Klotho NeurosciencesN/AN/A Which has stronger valuation and earnings, ALLR or KLTO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllarity TherapeuticsN/AN/A-$11.90MN/AN/AKlotho NeurosciencesN/AN/A$1.35MN/AN/A Is ALLR or KLTO more profitable? Klotho Neurosciences' return on equity of 0.00% beat Allarity Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Allarity TherapeuticsN/A -369.67% -100.06% Klotho Neurosciences N/A N/A -25.89% SummaryKlotho Neurosciences beats Allarity Therapeutics on 6 of the 8 factors compared between the two stocks. Get Klotho Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLTO vs. The Competition Export to ExcelMetricKlotho NeurosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.62M$3.00B$5.57B$7.83BDividend YieldN/A1.89%5.11%4.22%P/E RatioN/A30.4222.4418.48Price / SalesN/A498.92394.09103.59Price / Cash0.95168.6838.1834.62Price / Book-0.083.206.774.25Net Income$1.35M-$72.35M$3.22B$248.23M7 Day Performance3.77%1.46%1.49%0.89%1 Month Performance-27.95%8.79%4.00%3.53%1 Year PerformanceN/A-22.36%16.21%5.08% Klotho Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLTOKlotho NeurosciencesN/A$0.17-2.9%N/AN/A$4.62MN/A0.00N/AALLRAllarity Therapeutics0.3037 of 5 stars$1.03+9.6%N/A-96.9%$17.53MN/A0.0010NAIINatural Alternatives International0.8436 of 5 stars$2.61-6.1%N/A-52.0%$17.21M$121.85M-2.02290Analyst ForecastGap DownHigh Trading VolumeCMMBChemomab Therapeutics3.5841 of 5 stars$1.16+3.6%$9.00+675.9%+92.9%$16.66MN/A-1.1620Short Interest ↓News CoverageGap UpEDSAEdesa Biotech3.0965 of 5 stars$2.38+5.3%$21.00+782.4%-47.6%$16.64MN/A-1.2720Short Interest ↓Gap UpSLGLSol-Gel Technologies2.3656 of 5 stars$0.59+6.4%$5.00+754.7%+6.7%$16.30M$11.71M-1.7250Short Interest ↑Gap DownHigh Trading VolumeEQEquillium2.7887 of 5 stars$0.46-3.7%$3.00+559.1%-71.8%$16.26M$41.10M-3.2540Upcoming EarningsShort Interest ↓LPCNLipocine2.5453 of 5 stars$3.01+0.3%$10.00+232.2%-28.4%$16.05M$11.20M-3.9610Gap UpCINGCingulate2.4774 of 5 stars$4.07-4.0%$30.67+653.5%+350.8%$16.04MN/A-0.2820Short Interest ↑News CoverageUBXUnity Biotechnology4.1077 of 5 stars$0.94-3.1%$5.33+467.6%-26.6%$15.85M$240,000.00-0.7260Analyst RevisionBFRGBullfrog AI0.4706 of 5 stars$1.66flatN/A-43.6%$15.63M$60,000.00-1.954Short Interest ↑ Related Companies and Tools Related Companies Allarity Therapeutics Competitors Natural Alternatives International Competitors Chemomab Therapeutics Competitors Edesa Biotech Competitors Sol-Gel Technologies Competitors Equillium Competitors Lipocine Competitors Cingulate Competitors Unity Biotechnology Competitors Bullfrog AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLTO) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Klotho Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Klotho Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KLTO Stock Free KLTO Stock Alerts